Home All aspects of galactosemia: a single center experience
Article
Licensed
Unlicensed Requires Authentication

All aspects of galactosemia: a single center experience

  • Abdurrahman Akgun EMAIL logo and Yasar Dogan
Published/Copyright: November 21, 2022

Abstract

Objectives

Classic galactosemia is a galactose metabolism disorder due to galactose-1-phosphate uridyltransferase deficiency. In this study we report the clinical features of a cohort of children with classic galactosemia.

Methods

A retrospective evaluation was made of the files of 42 cases followed up for a diagnosis of classic galactosemia between January 2000 and December 2021. The data were collected of clinical, laboratory and genetic characteristics.

Results

The cases comprised of 25 (59.5%) girls and 17 (40.5%) boys with a median age of 15 days (range, 1 day to 9 years) at diagnosis. In addition, thirty-six cases (92.3%) could be diagnosed before they were 4 months old by hospitalization with various clinical findings, primarily liver dysfunction. The most common complaints on presentation were jaundice (78.4%) and vomiting (27%) and the most frequently seen genetic pathogenic variant was c.563A>G (p.Gln188Arg) (92.4%).

Conclusions

It can be emphasized that there is a need for a neonatal screening program for classic galactosemia to be able to increase the possibility of early diagnosis and to be able to start treatment before the development of a severe clinical picture.


Corresponding author: Abdurrahman Akgun, Assistant professor, Department of Pediatrics, Division of Metabolism, Firat University School of Medicine, University Road, Yunus Emre Avenue, no:20, 23200, Elazig, Turkey, E-mail:

Acknowledgments

We would like to thank the management and staff of Firat University Hospital for their contributions.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Since the article does not contain personal information, informed consent was not obtained from the patients included in this study.

  5. Ethical approval: This study was approved by the Local Ethics Committee of the Firat University School of Medicine (protocol no: 6,276, date: 21 Jan 2022).

  6. Correspondence: AA is the guarantor of the article.

References

1. Berry, GT, Walter, J, Fridovich-Keil, JL. Disorders of galactose metabolism. In: Saudubray, JM, Baumgartner, MR, Walter, J, editors. Inborn metabolic diseases. Springer; 2016:139–47 pp.10.1007/978-3-662-49771-5_6Search in Google Scholar

2. Welsink-Karssies, MM, Ferdinandusse, S, Geurtsen, GJ, Hollak, CEM, Huidekoper, HH, Janssen, MCH, et al.. Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers. Brain Commun 2020;2:fcaa006. https://doi.org/10.1093/braincomms/fcaa006.Search in Google Scholar PubMed PubMed Central

3. Atik, SU, Gursoy, S, Kockar, T, Onal, H, Adal, SE. Clinical, molecular, and genetic evaluation of galactosemia in Turkish children. Turk Pediatri Ars 2016;51:204–9. https://doi.org/10.5152/turkpediatriars.2016.3759.Search in Google Scholar

4. Berry, GT. Classic galactosemia and clinical variant galactosemia. In: Adam, MP, Mirzaa, GM, Pagon, RA, Wallace, SE, Bean, LJH, Gripp, KW, et al., editors. GeneReviews((R)). Seattle, WA; 1993.Search in Google Scholar

5. Demirbas, D, Coelho, AI, Rubio-Gozalbo, ME, Berry, GT. Hereditary galactosemia. Metabolism 2018;83:188–96. https://doi.org/10.1016/j.metabol.2018.01.025.Search in Google Scholar PubMed

6. Timson, DJ. Therapies for galactosemia: a patent landscape. Pharm Pat Anal 2020;9:45–51. https://doi.org/10.4155/ppa-2020-0004.Search in Google Scholar PubMed

7. Mackinnon, SR, Krojer, T, Foster, WR, Diaz-Saez, L, Tang, M, Huber, KVM, et al.. Fragment screening reveals starting points for rational design of galactokinase 1 inhibitors to treat classic galactosemia. ACS Chem Biol 2021;16:586–95. https://doi.org/10.1021/acschembio.0c00498.Search in Google Scholar PubMed PubMed Central

8. Demirkol, M, Baykal, T, Hüner, G, Şarbat, G, İnce, Z, Kurdoğlu, G. Newborn screening for biotidinase deficiency: a pilot study from İstanbul. In: Diagnosis and treatment of inborn errors of metabolism: contribution to an equal opportunity for children in Asia and Europe Istanbul. Turkish Society for PKU Istanbul Branch; 1996:23–6 pp.Search in Google Scholar

9. Thornton, PS, Stanley, CA, Leon, DDD, Harris, D, Haymond, MW, Hussain, K, et al.. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr 2015;167:238–45. https://doi.org/10.1016/j.jpeds.2015.03.057.Search in Google Scholar PubMed

10. Rubio-Gozalbo, ME, Haskovic, M, Bosch, AM, Burnyte, B, Coelho, AI, Cassiman, D, et al.. The natural history of classic galactosemia: lessons from the GalNet registry. Orphanet J Rare Dis 2019;14:86. https://doi.org/10.1186/s13023-019-1047-z.Search in Google Scholar PubMed PubMed Central

11. Waggoner, DD, Buist, NR, Donnell, GN. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 1990;13:802–18. https://doi.org/10.1007/bf01800204.Search in Google Scholar PubMed

12. Kisa, PT, Kose, M, Unal, O, Er, E, Hismi, BO, Bulbul, FS, et al.. Clinical and molecular characteristics and time of diagnosis of patients with classical galactosemia in an unscreened population in Turkey. J Pediatr Endocrinol Metab 2019;32:675–81. https://doi.org/10.1515/jpem-2018-0457.Search in Google Scholar PubMed

13. Honeyman, MM, Green, A, Holton, JB, Leonard, JV. Galactosaemia: results of the British paediatric surveillance unit study, 1988-90. Arch Dis Child 1993;69:339–41. https://doi.org/10.1136/adc.69.3.339.Search in Google Scholar PubMed PubMed Central

14. Lindner, M, Gramer, G, Haege, G, Fang-Hoffmann, J, Schwab, KO, Tacke, U, et al.. Efficacy and outcome of expanded newborn screening for metabolic diseases-report of 10 years from South-West Germany. Orphanet J Rare Dis 2011;6:44. https://doi.org/10.1186/1750-1172-6-44.Search in Google Scholar PubMed PubMed Central

15. Ohlsson, A, Guthenberg, C, von Dobeln, U. Galactosemia screening with low false-positive recall rate: the Swedish experience. JIMD Rep 2012;2:113–7.10.1007/8904_2011_59Search in Google Scholar PubMed PubMed Central

16. Item, C, Hagerty, BP, Muhl, A, Greber-Platzer, S, Stockler-Ipsiroglu, S, Strobl, W. Mutations at the galactose-1-p-uridyltransferase gene in infants with a positive galactosemia newborn screening test. Pediatr Res 2002;51:511–6. https://doi.org/10.1203/00006450-200204000-00018.Search in Google Scholar PubMed

17. Yuzyuk, T, Viau, K, Andrews, A, Pasquali, M, Longo, N. Biochemical changes and clinical outcomes in 34 patients with classic galactosemia. J Inherit Metab Dis 2018;41:197–208. https://doi.org/10.1007/s10545-018-0136-9.Search in Google Scholar PubMed

18. Khokhar, SK, Pillay, G, Dhull, C, Agarwal, E, Mahabir, M, Aggarwal, P. Pediatric cataract. Indian J Ophthalmol 2017;65:1340–9. https://doi.org/10.4103/ijo.ijo_1023_17.Search in Google Scholar PubMed PubMed Central

19. Garcia, DF, Camelo, JSJr, Molfetta, GA, Turcato, M, Souza, CF, Porta, G, et al.. Clinical profile and molecular characterization of galactosemia in Brazil: identification of seven novel mutations. BMC Med Genet 2016;17:39. https://doi.org/10.1186/s12881-016-0300-8.Search in Google Scholar PubMed PubMed Central

20. Shakespeare, L, Downing, M, Allen, J, Casbolt, AM, Ellin, S, Maloney, M, et al.. Elevated phenylalanine on newborn screening: follow-up testing may reveal undiagnosed galactosaemia. Ann Clin Biochem 2010;47:567–9. https://doi.org/10.1258/acb.2010.010083.Search in Google Scholar PubMed

21. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. Available from: http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GALT [Accessed 06 Feb 2022].Search in Google Scholar

22. Demirbas, D, Huang, X, Daesety, V, Feenstra, S, Haskovic, M, Qi, W, et al.. The ability of an LC-MS/MS-based erythrocyte GALT enzyme assay to predict the phenotype in subjects with GALT deficiency. Mol Genet Metabol 2019;126:368–76. https://doi.org/10.1016/j.ymgme.2019.01.016.Search in Google Scholar PubMed

23. Ozgul, RK, Guzel-Ozanturk, A, Dundar, H, Yucel-Yilmaz, D, Coskun, T, Sivri, S, et al.. Galactosemia in the Turkish population with a high frequency of Q188R mutation and distribution of Duarte-1 and Duarte-2 variations. J Hum Genet 2013;58:675–8. https://doi.org/10.1038/jhg.2013.76.Search in Google Scholar PubMed

24. Crespo, C, Eiroa, H, Otegui, MI, Bonetto, MC, Chertkoff, L, Gravina, LP. Molecular analysis of GALT gene in Argentinian population: correlation with enzyme activity and characterization of a novel Duarte-like allele. Mol Genet Metab Rep 2020;25:100695. https://doi.org/10.1016/j.ymgmr.2020.100695.Search in Google Scholar PubMed PubMed Central

25. Jezela-Stanek, A, Bauer, A, Wertheim-Tysarowska, K, Bal, J, Rygiel, AM, Sykut-Cegielska, J. The genetic basis of classical galactosaemia in polish patients. Orphanet J Rare Dis 2021;16:239. https://doi.org/10.1186/s13023-021-01869-3.Search in Google Scholar PubMed PubMed Central

26. Welling, L, Bernstein, LE, Berry, GT, Burlina, AB, Eyskens, F, Gautschi, M, et al.. Galactosemia Network (GalNet). International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis 2017;40:171–6. https://doi.org/10.1007/s10545-016-9990-5.Search in Google Scholar PubMed PubMed Central


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2022-0308).


Received: 2022-06-18
Accepted: 2022-11-04
Published Online: 2022-11-21
Published in Print: 2023-01-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Disorders of sex development – biologic, genetic, cultural, societal, and psychologic diversity of the human nature
  4. Review
  5. Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement
  6. Original Articles
  7. Penile diameter during puberty in boys: a retrospective analysis of longitudinally obtained data
  8. Evaluation of bladder dysfunction in children and adolescents with type 1 diabetes mellitus by uroflowmetry
  9. All aspects of galactosemia: a single center experience
  10. The evolution of pituitary cysts in growth hormone-treated children
  11. Phototherapy-induced hypocalcemia and hypoparathyroidism in icteric term newborns
  12. Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience
  13. Does cystatin C have an immunomodulatory role in Hashimoto’s thyroiditis?
  14. Molecular genetic etiology by whole exome sequence analysis in cases with familial type 1 diabetes mellitus without HLA haplotype predisposition or incomplete predisposition
  15. Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review
  16. Case Reports
  17. Congenital adrenal hyperplasia with a CYP21A2 deletion overlapping the tenascin-X gene: an atypical presentation
  18. The smallest dislocated microduplication of Xq27.1 harboring SOX3 gene associated with XX male phenotype
  19. Rare PHEX intron variant causes complete and severe phenotype in a family with hypophosphatemic rickets: a case report
  20. Human chorionic gonadotrophin secreting adrenocortical neoplasm presenting with peripheral precocious puberty in an infant
  21. Atypical familial diabetes associated with a novel NEUROD1 nonsense variant
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0308/html
Scroll to top button